Ototoxicity: Bioprotective mechanisms

Current Opinion in Otolaryngology and Head and Neck Surgery

Volumn 11, Issue 5, 2003, Pages 328-333

  Rybak, Leonard P ^a   Kelly, Thomas ^a  

^a SOUTHERN ILLINOIS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Aminoglycoside; Cisplatin; Ototoxicity

Indexed keywords

2,2' BIPYRIDINE; ACETYLCYSTEINE; ALPHA TOCOPHEROL; AMINO ACID DERIVATIVE; AMINOGLYCOSIDE ANTIBIOTIC AGENT; ANTIOXIDANT; BENZYLOXYCARBONYLVALYLALANYLASPARTYL FLUOROMETHYL KETONE; CALCIUM CHELATING AGENT; CASPASE INHIBITOR; CEP 1347; CISPLATIN; CYCLOHEXIMIDE; FAS ANTIGEN; GLUTATHIONE; GLUTATHIONE REDUCTASE; IRON CHELATING AGENT; LEUPEPTIN; MALONALDEHYDE; MANGANESEDICHLORO(3,10,13,20,26 PENTAAZATETRACYCLO[20.3.1.0(4,9).0(14,19)] 1(26),22(23),24 HEXACOSATRIENE); METHIONINE; N(G) NITROARGININE METHYL ESTER; NEOMYCIN; NEUROTROPIN; PROTECTIVE AGENT; QUIN 2 AM; REACTIVE OXYGEN METABOLITE; SALICYLIC ACID DERIVATIVE; STRESS ACTIVATED PROTEIN KINASE; THIOUREA; UNINDEXED DRUG;

ACIDITY; ALKALINITY; APOPTOSIS; AUDITORY RESPONSE; CELL PROTECTION; COCHLEA; DRUG PENETRATION; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE THERAPY; HAIR CELL; HUMAN; LIGAND BINDING; LIPID PEROXIDATION; MITOCHONDRION; NEPHROTOXICITY; NONHUMAN; OTOTOXICITY; OXIDATIVE STRESS; PREMEDICATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION;

AMINOGLYCOSIDES; ANTI-BACTERIAL AGENTS; ANTINEOPLASTIC AGENTS; CISPLATIN; EAR DISEASES; HUMANS;

EID: 0141506087     PISSN: 10689508     EISSN: None     Source Type: Journal    
DOI: 10.1097/00020840-200310000-00004     Document Type: Review

References (41)

1. Tan CT, Lee SY, Yao CJ, et al.: Effects of gentamicin and pH on [Ca2+], in apical and basal outer hair cells from guinea pigs. Hear Res 2001, 154:81-87.
2. Teranishi M, Nakashima T, Wakabayashi T: Effects of alpha-tocopherol on cisplatin-induced ototoxicity in guinea pigs. Hear Res 2001, 151:61-70.
3. Teranishi M, Nakashima T: Effects of trolox, locally applied on round windows, on cisplatin-induced ototoxicity in guinea pigs. Int J Pediatr Otorhinolaryngol 2003, 67:133-139.
4. Korver KD, Rybak LP, Whitworth CA, et al.: Round window application of D-methionine provides complete cisplatin otoprotection. Otolaryngol Head Neck Surg 2002, 126:683-689.
5. Li G, Frenz DA, Brahmblatt S, et al.: Round window membrane delivery of L-methionine provides protection from cisplatin ototoxicity without compromising chemotherapeutic efficacy. NeuroToxicol 2001, 22:163-176.
6. Li G, Sha S-H, Zotova E, et al.: Salicylate protects hearing and kidney function without compromising its oncolytic action. Lab Invest 2002, 82:585-596. This study demonstrates the efficacy of sodium salicylate in preventing cisplatin ototoxicity and nephretoxicity without compromising the antineoplastic effect in tumor-bearing rats.
7. Dehne N, Lautermann J, Petrat F, et al.: Cisplatin ototoxicity: involvement of iron and enhanced formation of superoxide anion radicals. Toxicol Appl Pharmacol 2001, 174:27-34.
8. McFadden SL, Ding D, Salvemini D, et al.: M40403, a superoxide dismutase mimetic, protects cochlear hair cells from gentamicin, but not cisplatin toxicity. Toxicol Appl Pharmacol 2003, 186:46-54.
9. Feghali JG, Liu W, Van De Water TR: L-N-acetyl cysteine protection against cisplatin-induced auditory neuronal and hair cell toxicity. Laryngoscope 2001, 111:1147-1155.
10. Laurell G, Teixeira M, Sterkers O, et al.: Local administration of antioxidants to the inner ear. Kinetics and distribution. Hear Res 2002, 173:198-209.
11. Lefebvre PP, Malgrange B, Lallemend F, et al.: Mechanisms of cell death in the injured auditory system: otoprotective strategies. Audiol Neurootol 2002, 7:165-170. This article provides a series of strategies to be considered in developing a strategy to protect the cochlea against damage from cisplatin.
12. Bowers WJ, Chen X, Guo H, et al.: Neurotrophin-3 transduction attenuates cisplatin spiral ganglion ototoxicity in the cochlea. Mol Ther 2002, 6:12-18. This study raises the prospect for gene therapy to deliver protective molecules to the inner ear to prevent ototoxic damage to the spiral ganglion cells.
13. Tanaka F, Whitworth CA, Rybak LP: Influence of pH on the ototoxicity of cisplatin: a round window study. Hear Res 2003, 177:21-31.
14. Deegan P, Pratt I, Ryan M: The nephrotoxicity, cytotoxicity and renal handling of a cisplatin-methionine complex in male Wistar rats. Toxicology 1994, 89:1-14.
15. Ekborn A, Laurell G, Johnstrom P, et al.: D-methionine and cisplatin ototoxicity in the guinea pig: D-methionine influences cisplatin pharmacokinetics. Hear Res 2002, 165:53-61.
16. Ekborn A, Lindberg A, Laurell G, et al.: Ototoxicity, nephrotoxicity and pharmacokinetics of cisplatin and its monohydrated complex in the guinea pig. Cancer Chemother Pharmacol 2003, 51:36-42.
17. Campbell KCM, Larsen DL, Meech RP, et al.: Glutathione ester, but not glutathione, protects against cisplatin-induced ototoxicity in a rat model. J Am Acad Audiol 2003, 14:124-133.
18. Campbell KCM, Meech RP, Rybak LP, et al.: The effect of D-methionine on cochlear oxidative state with and without cisplatin administration: mechanisms of otoprotection. J Am Acad Audiol 2003, 14:144-156.
19. Bodmer D, Brors D, Pak P, et al.: Gentamicin-induced hair cell death is not dependent on the apoptosis receptor Fas. Laryngoscope 2003, 113:452-455.
20. Matsui JI, Ogilvie JM, Warchol ME: Inhibition of caspases prevents ototoxic and ongoing hair cell death. J Neurosci 2002, 22:1218-1227.
21. Cunningham LL, Cheng AG, Rubel EW: Caspase activation in hair cells of the mouse utricle exposed to neomycin. J Neurosci 2002, 22:8532-8540.
22. Strasser A, O'Connor L, Dixit VM: Apoptosis signaling. Annu Rev Biochem 2000, 69:217-245.
23. Yuan J, Yankner BA: Apoptosis in the nervous system. Nature 2000, 407:802-809.
24. Cheng AG, Cunningham LL, Rubel EW: Translocation of cytochrome c in hair cells of gentamicin-treated avian basilar papilla. Abstracts of the Twenty-Fifth Annual Midwinter Research Meeting of the Association for Research in Otolaryngology 2002, 25:134.
25. Alam SA, Ikeda K, Oshima T, et al.: Cisplatin-induced apoptotic cell death in Mongolian gerbil cochlea. Hear Res 2000, 141:28-38.
26. Nakagawa T, Yamane H: Cytochrome c redistribution in apoptosis of guinea pig vestibular hair cells. Brain Res 1999, 847:357-359.
27. Dehne N, Rauen U, de Groot H, et al.: Involvement of the mitochondrial permeability transition in gentamicin ototoxicity. Hear Res 2002, 169:47-55.
28. Jacotot E, Costantini P, Laboureau E, et al.: Mitochondrial membrane permeabilization during the apoptotic process. Ann N Y Acad Sci 1999, 887:18-30.
29. Ylikoski J, Xing-Qun L, Virkkala J, et al.: Blockade of c-JUN N-terminal kinase pathway attenuates gentamicin-induced cochlear and vestibular hair cell death. Hear Res 2002, 166:33-43.
30. Bodmer D, Brors D, Pak K, et al.: Rescue of auditory hair cells from aminoglycoside toxicity by Clostridium difficile toxin B, an inhibitor of the small GTPases Rho/Rac/Cdc42. Hear Res 2002, 172:81-86.
31. Finkel T: Oxygen radicals and signaling. Curr Opin Cell Biol 1998, 10:248-253.
32. Lo YCC, Wong JMS, Cruz TF: Reactive oxygen species mediate cytokine activation of c-Jun NH2-terminal kinases. J Biol Chem 1996, 271:15703-15707.
33. Adler V, Yin Z, Tew KD, et al.: Role of redox potential and reactive oxygen species in stress signaling. Oncogene 1999, 18:6104-6111.
34. Meriin AB, Gabai VL, Yaglom J, et al.: Proteasome inhibitors activate stress kinases and induce Hsp 72. J Biol Chem 1998, 273:6373-6379.
35. Ip YT, Davis RJ: Signal transduction by the c-JUN N-terminal kinase (JNK)-from inflammation to development. Curr Opin Cell Biol 1998, 10:205-219.
36. Takumida M, Anniko M, Shimizu A, et al.: Neuroprotection of vestibular sensory cells from gentamicin ototoxicity obtained using nitric oxide synthase inhibitors, reactive oxygen species scavengers, brain-derived neurotrophic factors and calpain inhibitors. Acta Otolaryngol 2003, 123:8-13.
37. Fetoni AR, Sergi B, Scarano E, et al.: Protective effects of alpha-tocopherol against gentamicin-induced oto-vestibulo toxicity: an experimental study. Acta Otolaryngol 2003, 123:192-197.
38. Zhuravskii SG, Lopotko AI, Tomson VV, et al.: Protective effect of calcium channel blocker verapamil on morphological and functional state of hair cells of the organ of Corti in experimental kanamycin-induced ototoxicity: Bull Exp Biol Med 2002, 133:404-407.
39. Ding D, Stracher A, Salvi R: Leupeptin protects cochlear and vestibular hair cells from gentamicin ototoxicity. Hear Res 2002, 164:115-126.
40. Hirose K, Westrum LE, Stone JS, et al.: Dynamic studies of ototoxicity in mature avian auditory epithelium. Ann N Y Acad Sci 1999, 884:389-409.
41. Himeno C, Komeda M, Izumikawa M, et al.: Intra-cochlear administration of dexamethasone attenuates aminoglycoside ototoxicity in the guinea pig. Hear Res 2002, 167:61-70.